• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-
 

2006 Warning Letters

-

Recently Posted | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |

Tobacco Retailer Warning Letters

 

-

Recently Posted | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

Warning Letters issued in 2006

 

* Not issued: A close-out letter may issue when, based on FDA’s evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009.

* N/A: Not applicable, the Warning Letter was issued prior to September 1, 2009.

Read more about warning and close-out letters

 
Letter Issue Date Company Name Issuing Office Subject Close Out Date
January 31, 2006 Mammography & Ultrasound Specialists [ARCHIVED] Dallas District Office Mammography Quality Standards N/A *
January 30, 2006 Murrock Farms [ARCHIVED] New York District Office Illegal Drug Residue N/A *
January 30, 2006 The Long Life Catalog Company [ARCHIVED] New England District Office Labeling/Promotional Claims False & Misleading/New Drug N/A *
January 30, 2006 Neuro-Fitness, L.L.C. [ARCHIVED] Seattle District Office Lacks Premarket Approval Application Misbranded N/A *
January 27, 2006 RxIBR Corporation [ARCHIVED] Dallas District Office Labeling/Promotional Claims False & Misleading/New Drug/Misbranded N/A *
January 27, 2006 Price, David [ARCHIVED] Dallas District Office Labeling/Promotional Claims False & Misleading/New Drug/Misbranded N/A *
January 26, 2006 Del-Immune V [ARCHIVED] Denver District Office Labeling/Promotional Claims False & Misleading/New Drug N/A *
January 26, 2006 Barbland Farms, Inc. [ARCHIVED] New York District Office Illegal Drug Residue N/A *
January 25, 2006 Boston Scientific Corporation [ARCHIVED] New England District Office CGMP for Medical Devices/Medical Device Reporting/Misbranded N/A *
January 24, 2006 Davis, Robert [ARCHIVED] Florida District Office Labeling/Promotional Claims False & Misleading/New Drug/Misbranded N/A *
January 24, 2006 ZLB Behring [ARCHIVED] Kansas City District Office CGMP Regulations for Blood and Blood Components N/A *
January 24, 2006 Health Authority LLC [ARCHIVED] Florida District Office Labeling/Promotional Claims False & Misleading/New Drug/Misbranded N/A *
January 23, 2006 Raytel Medical Imaging [ARCHIVED] New York District Office Mammography Quality Standards N/A *
January 23, 2006 Human Investigation Committee of Houston, Texas [ARCHIVED] Center for Drug Evaluation and Research Institutional Review Board (IRB) N/A *
January 20, 2006 International BioResources, LLC [ARCHIVED] Minneapolis District Office CGMP For Blood & Blood Components N/A *
January 18, 2006 K & D Produce, Inc. [ARCHIVED] Florida District Office CGMP Regulations for Blood and Blood Components N/A *
January 17, 2006 National Genetics Institute [ARCHIVED] Los Angeles District Office Quality System Regulation/CGMP For Blood & Blood Components N/A *
January 17, 2006 Filo Corporation [ARCHIVED] Florida District Office Control of Communicable Disease N/A *
January 13, 2006 Cache Commodities, Inc. [ARCHIVED] Denver District Office CGMP Requirements For Medicated Feeds/Adulterated N/A *
January 12, 2006 Wicked Lasers World Headquarter [ARCHIVED] Center for Devices and Radiological Health Performance Standards for Light Emitting Products N/A *



-
 

Contact FDA

ICECI Warning Letters

Division of Freedom of Information (HFI-35)

Food and Drug Administration

5600 Fishers Lane

Rockville, MD 20857
-
-
-
-